Request for Proposals (RFP) Notice: Purity Specifications, Storage and Distribution for Medications Development

Notice Number: NOT-DA-17-061

Key Dates
Release Date:  February 22, 2017

Related Announcements
 NOT-DA-17-060

Issued by
National Institute on Drug Abuse (NIDA)

Purpose

The National Institute on Drug Abuse (NIDA) plans to solicit proposals under full and open competition procedures from qualified organizations having the capability to act as a centralized repository for compounds from domestic and international investigators, commercial sources, and pharmaceutical companies. Specifically, the project requires the following tasks:

Receive and store compounds from various sources:

Store approximately 4,000 existing compounds ranging in quantity from milligrams to kilograms
Store compounds in various conditions ranging from room temperature to -70° C; from inert atmosphere to desiccated atmosphere; and from high security storage to normal lock and key
Receive and store new compounds received from various sources
Obtain proper permits and coordinate logistics for receipt of compounds from foreign sources
Dispose of compounds that may potentially be neurotoxins or biohazardous

Purchase commercially available compounds:

Acquire compounds from commercial suppliers
Obtain and transpose all analytical information (e.g., complete chemical structure, solubility, etc.) for purchased compounds

Analyze compounds received from various sources:

Perform Thin Layer Chromatography (TLC) analysis
Perform High Performance Liquid Chromatography (HPLC) analysis
Perform Mass Spectrometry (MS) analysis
Perform Nuclear Magnetic Resonance (NMR) analysis
Interpret and report results to the COR

Ship compounds to domestic and international test sites:

Package and ship compounds
Prepare shipments as blinded samples
Prepare shipments according to specified shipping conditions (i.e., dry ice, inert environment, desiccant, etc.)

Maintain an extensive, secure, web-based inventory and tracking system

Maintain a centralized database tracking receipt, analysis, inventory coding, distribution, and other data for all compounds
Update database on a daily basis
Secure and maintain all records confidentially
Meet DEA record keeping requirements for scheduled compounds

NIDA anticipates the award of a single, one year, cost reimbursement contract with four one year option periods. This award is a competitive renewal of HHSN271201200010C, titled "Purity Specifications, Storage and Distribution for Medications Development."

Mandatory Criteria

In order to handle substances under the Controlled Substances Act of 1970, it is mandatory that offerors possess a DEA Registration for Chemical Analysis or Research Registration for Schedules II to V and demonstrate the capability to obtain a DEA registration for Schedule I controlled substances.

Notice

RFP No. N01DA-17-8934 is available electronically through the FedBizOpps (URL: http://fedbizopps.gov) or through the NIDA website (URL: http://www.drugabuse.gov/funding/funding-opportunities/nida-requests-contract-proposals-rfps). All information required for the submission of a proposal will be contained in or accessible through the RFP package. Responses to the RFP will be due Monday, April 03, 2017.

Based upon market research, the Government is not using the policies contained in Part 12, Acquisition of Commercial Items, in its solicitation for the described supplies or services. However, interested persons or organizations may identify to the Contracting Officer their interest and capability to satisfy the Government's requirement with a commercial item within 15 days of this notice.

This advertisement does not commit the Government to award a contract.

Inquiries

Please direct all inquiries to:

Kenneth Janosko
National Institute on Drug Abuse (NIDA)
Telephone: 301-443-6677
Email: kenneth.janosko@nih.gov